Evidence map›Paper›PMID 25313082›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Characterization of HPV and host genome interactions in primary head and neck cancers.

Michael Parfenov, Chandra Sekhar Pedamallu, Nils Gehlenborg, Samuel S Freeman, Ludmila Danilova, Christopher A Bristow, Semin Lee, Angela G Hadjipanayis, Elena V Ivanova, Matthew D Wilkerson and 27 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 244 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
244citing papers in PubMed, 2 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

244 citing papers in PubMed, 2 syntheses or guidelines pooled it, 387 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. HPV in oropharyngeal squamous papillomas: a missing link in head and neck viral pathogenesis.Virchows Archiv : an international journal of pathology · 2026
    Article
  7. Article
  8. HPV Integration in Head and Neck Cancer: Downstream Splicing Events and Expression Ratios Linked with Poor Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 14 institutions in 2 countries.

Michael ParfenovDepartments of Genetics and.
Chandra Sekhar PedamalluDepartment of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
Nils GehlenborgThe Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
Samuel S FreemanThe Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
Ludmila DanilovaThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287;
Christopher A BristowInstitute for Applied Cancer Science, Department of Genomic Medicine and.
Semin LeeCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
Angela G HadjipanayisDepartments of Genetics and.
Elena V IvanovaDepartment of Medical Oncology and Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02115;
Matthew D WilkersonLineberger Comprehensive Cancer Center and Department of Genetics and.
Alexei ProtopopovInstitute for Applied Cancer Science, Department of Genomic Medicine and.
Lixing YangCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
Sahil SethInstitute for Applied Cancer Science, Department of Genomic Medicine and.
Xingzhi SongInstitute for Applied Cancer Science, Department of Genomic Medicine and.
Jiabin TangInstitute for Applied Cancer Science, Department of Genomic Medicine and.
Xiaojia RenDepartments of Genetics and.
Jianhua ZhangInstitute for Applied Cancer Science, Department of Genomic Medicine and.
Angeliki PantaziDepartments of Genetics and.
Netty SantosoDepartments of Genetics and.
Andrew W XuCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
Harshad MahadeshwarInstitute for Applied Cancer Science, Department of Genomic Medicine and.
David A WheelerHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030;
Robert I HaddadDepartment of Medical Oncology, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Boston, MA 02215;
Joonil JungThe Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
Akinyemi I OjesinaDepartment of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
Natalia IssaevaDepartment of Surgery, Division of Otolaryngology, Yale School of Medicine, New Haven, CT 06520-8041;
Wendell G YarbroughDepartment of Surgery, Division of Otolaryngology, Yale School of Medicine, New Haven, CT 06520-8041;
D Neil HayesLineberger Comprehensive Cancer Center and Department of Internal Medicine, Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
Jennifer R GrandisDepartments of Otolaryngology and Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and.
Adel K El-NaggarDepartments of Pathology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
Matthew MeyersonDepartment of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; Pathology and.
Peter J ParkCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
Lynda ChinThe Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; Institute for Applied Cancer Science, Department of Genomic Medicine and.
J G SeidmanDepartments of Genetics and seidman@genetics.med.harvard.edu peterh@broadinstitute.org rkucherlapati@partners.org.
Peter S HammermanDepartment of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; seidman@genetics.med.harvard.edu peterh@broadinstitute.org rkucherlapati@partners.org.
Raju KucherlapatiHarvard Medical School, Partners HealthCare Center for Genetics and Genomics, Boston, MA 02115 seidman@genetics.med.harvard.edu peterh@broadinstitute.org rkucherlapati@partners.org.
Cancer Genome Atlas Network
Broad Institute · USThe University of Texas MD Anderson Cancer Center · USEmory University · USHarvard University · USHarvard University Press · USUniversity of North Carolina at Chapel Hill · USDana-Farber Cancer Institute · USMassachusetts Institute of Technology · USBaylor College of Medicine · USYale University · USJohns Hopkins University · USUniversity of Pittsburgh · USInstitute for Applied Science · GBUNC Lineberger Comprehensive Cancer Center

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Genome Characterization Center (GCC)U24CA143867 · NCI · BROAD INSTITUTE, INC. · PI GABRIEL, STACEY, MEYERSON, MATTHEW L. · 2009 to 2016
$17.0M
Harvard Genome Characterization CenterU24CA144025 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHERLAPATI, RAJU S. · 2009 to 2016
$14.0M
The USC-JHU Cancer Epigenome Characterization CenterU24CA143882 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BAYLIN, STEPHEN B., WEISENBERGER, DANIEL JOSEPH · 2009 to 2016
$13.3M
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)U24CA143858 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI BENZ, CHRISTOPHER, HAUSSLER, DAVID H · 2009 to 2016
$8.9M
PI3K Pathway Mutations in Head and Neck CancerR01DE023685 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRANDIS, JENNIFER RUBIN, JOHNSON, DANIEL E · 2014 to 2023
$5.1M
GRPR Signaling in SCCHN: Integration with EGFRR01CA098372 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRANDIS, JENNIFER RUBIN · 2004 to 2017
$3.8M
Unlocking transcript diversity via differential analyses of splice graphsR01HG006272 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, JINZE, PRINS, JAN F · 2012 to 2014
$1.2M
Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung CancerK08CA163677 · NCI · DANA-FARBER CANCER INST · PI HAMMERMAN, PETER S · 2012 to 2016
$783k
Functionalizing recurrent FAT1 mutations and deletions in oral cancerK08DE024774 · NIDCR · SLOAN-KETTERING INST CAN RESEARCH · PI MORRIS, LUC GORDON TRANG · 2014 to 2018
$682k
NCI NIH HHS K08 CA163677NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA098372NCI NIH HHS U24 CA143858NCI NIH HHS U24 CA143867NCI NIH HHS U24 CA143882NCI NIH HHS U24 CA144025NHGRI NIH HHS R01 HG006272NIDCR NIH HHS K08 DE024774NIDCR NIH HHS R01 DE023685
6 · The paper itself

Abstract

Previous studies have established that a subset of head and neck tumors contains human papillomavirus (HPV) sequences and that HPV-driven head and neck cancers display distinct biological and clinical features. HPV is known to drive cancer by the actions of the E6 and E7 oncoproteins, but the molecular architecture of HPV infection and its interaction with the host genome in head and neck cancers have not been comprehensively described. We profiled a cohort of 279 head and neck cancers with next generation RNA and DNA sequencing and show that 35 (12.5%) tumors displayed evidence of high-risk HPV types 16, 33, or 35. Twenty-five cases had integration of the viral genome into one or more locations in the human genome with statistical enrichment for genic regions. Integrations had a marked impact on the human genome and were associated with alterations in DNA copy number, mRNA transcript abundance and splicing, and both inter- and intrachromosomal rearrangements. Many of these events involved genes with documented roles in cancer. Cancers with integrated vs. nonintegrated HPV displayed different patterns of DNA methylation and both human and viral gene expressions. Together, these data provide insight into the mechanisms by which HPV interacts with the human genome beyond expression of viral oncoproteins and suggest that specific integration events are an integral component of viral oncogenesis.

Indexed as

Base SequenceDNA MethylationGene Expression Regulation, NeoplasticGenes, NeoplasmGenome, HumanHead and Neck NeoplasmsHost-Pathogen InteractionsHumansMolecular Sequence DataPapillomaviridaeVirus Integrationcancergenome rearrangementhead and neckintegration sitespapilloma virus

Identifiers

PMID25313082
PMCPMC4217452
OpenAlexW1981646010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.